StockVS

NYSE · Health Information Services · USD

Veeva Systems Inc. (VEEV) Stock Analysis

Veeva Systems Inc. (VEEV) is a Health Information Services stock listed on NYSE and quoted in US Dollar.

VEEV

$275.09

−$9.29 (−3.27%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare VEEV with… →

VEEV Key Statistics

As of Sep 4, 2026
Trading
Open
$279.56
Previous Close
$284.38
Day's Range
273.61–279.86
52-Week Range
148.05–310.50
Volume
1.15M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.97
Valuation
Market Cap
$44.54B
P/E Ratio
45.02
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
26.86
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.24
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
12.88
EPS (ttm)Profit attributable to each share over the last twelve months.
6.11
Financials (FY)
Revenue (FY)
$3.20B+16.34%
Net Income (FY)
$908.91M+27.27%
Profit marginThe share of revenue left as profit after all costs and taxes.
29.34%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
161.91M
1-Year Return
+1.86%
Dividend and dates
Earnings Date
November 25, 2026estimated
Avg Volume
2.07M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

VEEV Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+23.23%
2025+6.17%
2024+9.21%
2023+19.30%
2022−36.83%
2021−6.16%
2020+93.55%
2019+57.48%
2018+61.58%
2017+35.82%
2016 (partial year)+6.29%

As of September 4, 2026.

VEEV Revenue and Earnings by Fiscal Year

FY ends January
Fiscal yearRevenueNet incomeNet margin
2025$3.20B$908.91M28.4%
2024$2.75B$714.14M26.0%
2023$2.36B$525.71M22.2%
2022$2.16B$487.71M22.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.20B$2.41B$916.37M$908.91M28.4%
2024$2.75B$2.05B$691.44M$714.14M26.0%
2023$2.36B$1.69B$429.33M$525.71M22.2%
2022$2.16B$1.55B$459.09M$487.71M22.6%

Annual figures as reported, in the company's reporting currency. As of January 31, 2026.

VEEV Valuation vs Health Information Services Median

Median of 53 stocks
MetricVEEVHealth Information Services medianvs median
P/E45.0241.139% above
P/S ratio12.882.664.8x the median
Profit margin29.34%0.00%29.3 pts above

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Veeva Systems Inc. (VEEV) at $44.54B. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 7,928 employees.

The most recent close on file for VEEV is $275.09, dated September 4, 2026. That is −$9.29 (−3.27%) against the previous close. The 52-week range on file runs from $148.05 to $310.50. The latest close sits 85.81% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $3.20B. Against the prior fiscal year total of $2.75B, that is a change of +16.34%. The same year closed with net income of $908.91M. That is +27.27% against the prior fiscal year. Profit margin runs at 29.35%. That is 29.3 percentage points above the Health Information Services median of 0%. Trailing earnings per share are 6.11.

Across the 4 fiscal years on file, revenue moves from $2.16B in 2022 to $3.20B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 45.02 times earnings. That is 9.46% above the Health Information Services median of 41.13. On forward earnings the ratio is 26.86. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.24. The price-to-sales ratio is 12.88. On price-to-sales that is 4.8 times the Health Information Services median of 2.66. The medians here are taken across 53 Health Information Services companies that report the metric.

The trailing one-year price return is +1.86%. Across 10 years the annualized return works out at +21.04%. The reported beta is 0.97. Annualized volatility over the trailing 10 years is 38.82%.

Growth & Income

The record shows no dividend for VEEV.

2026 is still running; the price is +23.23% year to date. The strongest complete calendar year on file is 2020 at +93.55%; the weakest is 2022 at −36.83%. Of the 9 complete calendar years on file, 7 finished higher.

Peer Comparison

Veeva Systems Inc. (VEEV) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B
HealthEquity, Inc. HQY $7.95B 35.7

The Health Information Services industry average P/E ratio is 41.1x. Veeva Systems Inc. trades at a P/E of 45.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

View all Health Information Services stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Veeva Systems Inc.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Visit website →